This is how the page reads now. Looks to have been updated not long ago. Could it be a hint as to the new product?
Tissue bio-implants developed using the ADAPT® tissue engineering process more closely mimic the characteristics of normal human tissue. This promotes a more tolerant immune response with improved tissue ingrowth. Tissue exposed to the ADAPT® process has been shown to have significantly improved functionality and longer term durability of the resulting bio-implant.
With the potential for a product lifespan free from calcification, clinicians may be able to intervene across a broader age spectrum and provide their patients with a solution for life.
CardioCel®, a cardiovascular scaffold, is the first of a suite of implantable tissues generated by ADAPT® that offer medical professionals a potential improvement over the products they currently use. CardioCel® has regulatory approval and is being used by surgeons in centres across Europe and the US. The product also recently gained licence approval in Canada, special access approval in Singapore and is available under the Authorised Prescriber Scheme in Australia.
Our technology also has applications in general and gynaecological surgery.
Click here for more information on the science behind ADAPT®
Bio-Implants
-
- There are more pages in this discussion • 48 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.00 |
Change
-0.300(1.64%) |
Mkt cap ! $346.0M | |||
| Open | High | Low | Value | Volume |
| $18.29 | $18.30 | $17.65 | $181.7K | 10.18K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 30 | $17.72 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.00 | 499 | 1 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |